Why Waiting for a Warning Letter Is the Most Expensive Compliance Strategy There Is – Video Transcript

What does it actually cost to wait for an FDA warning letter?

More than fixing the problem early, and on someone else’s schedule. A warning letter is FDA’s written notice that it has found significant violations, it is published on FDA’s own website, and it carries a response deadline of about fifteen working days. A response effort runs a minimum of tens of thousands of dollars; if it escalates into a recall, a minimum of hundreds of thousands, and it can climb far higher depending on scope.

What is an FDA warning letter, exactly?

It is FDA’s written notice that an inspection or review found significant violations. It identifies the violations, tells you what FDA expects you to correct, and asks for a written response — typically within about fifteen working days. FDA posts warning letters publicly on its own website, so the letter is not a private conversation between you and the agency.

Why is waiting more expensive than fixing it early?

Because the letter changes the nature of the work. Before a letter, a labeling or recordkeeping gap is a paperwork problem you can fix on your own timeline, one item at a time, at ordinary cost. After a letter, the same gap becomes a public deadline. You are paying for outside counsel, a written response on a short clock, and often corrective work across labels, records and suppliers simultaneously. A response effort runs a minimum of tens of thousands of dollars, and if the issue escalates into a recall, a minimum of hundreds of thousands.

What is the cost that never appears on an invoice?

Reputation with the people who decide whether you grow. Retailers read warning letters, and acquirers find them in diligence for years afterward. A letter that was answered and closed out still sits in the public record, and it still has to be explained to a buyer or a category manager long after the underlying issue was fixed.

What should be fixed first, before any letter arrives?

The inexpensive things, in this order. Labels, because they are the most frequently cited and the easiest to correct. Claims, because a claim you cannot substantiate is a violation you are publishing voluntarily. And your registration and listing status, because those are renewal-driven and lapse on a calendar rather than after an event, so nothing in day-to-day operations tells you they expired.

When is the right moment for a document review?

Before a launch or a new retail contract, not after a letter. Those are the two moments when a label, a claim or a registration gap is cheapest to correct and most consequential if missed. A single review before either one is the whole argument of this video.

Who should respond if a letter does arrive?

Decide that now, in writing: who owns the response, and who they call. The fifteen-day clock starts when the letter arrives, not when you finish deciding. Naming the responder and their outside counsel in advance is the difference between a measured response and a scramble.

Frequently asked questions

We have never been inspected. Does that change the math?

Not in your favor. An absence of inspection history is not evidence of compliance, and it usually means nobody outside the business has ever tested whether your records support what you sell.

Can we just respond to a warning letter ourselves and save the legal cost?

You can respond yourself, but the response is a regulatory document written to a short deadline that FDA will hold you to. The cost of an inadequate response is a second round, on a shorter clock, with less credibility.

Does the letter come down once we fix the problem?

FDA may issue a close-out letter once it is satisfied, but the original warning letter stays in the public record. That is why the diligence and retailer exposure outlasts the correction.

Our contract manufacturer got the letter, not us. Are we affected?

Very likely yes. Your product is made in their facility, and a buyer or retailer reviewing your supply chain will find it. See our video on whether your contract manufacturer’s compliance is actually your problem.

What does “fix the cheap things first” mean in practice?

One review of your current label artwork and every claim on your label and website against the substantiation you actually hold, plus confirmation that your facility registration and product listings are current. That is a defined, bounded piece of work — unlike a warning letter response, which is defined by FDA.

Fix the inexpensive things on your own timeline

Contact Capote Law Firm today.

Educational purposes only. This video and page are general information, not legal advice, and do not create an attorney-client relationship.